Status:

RECRUITING

Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Collaborating Sponsors:

American Heart Association

Conditions:

Atrial Fibrillation

Arrhythmias, Cardiac

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Atrial fibrillation (AF) affects 1 in 4 individuals during their lifetime and continues to increase in frequency and impact. Exercise intervention has established benefits to improve AF symptoms and b...

Eligibility Criteria

Inclusion

  • ≥40years of age
  • Paroxysmal AF
  • Electrocardiographic (or equivalent) documentation of AF within 12 months (would need to have evidence of AF after initial post-ablation blanking period if the patient had prior AF ablation)
  • AF Severity Scale (AFSS) symptom score 13-26
  • Self-report weekly moderate-vigorous physical activity (MVPA) 30-120 minutes

Exclusion

  • Unable to give consent
  • ≤90 days from AF ablation, coronary revascularization, heart failure hospitalization
  • Left ventricular ejection fraction (LVEF) \<50%, moderate to severe stenotic valvular heart disease or severe regurgitant valvular disease or history of mechanical valve replacement, presence of implanted pacemaker or defibrillator system
  • Labile INR or unable to take anticoagulant despite indication
  • Life expectancy \< 1 year
  • Hemodialysis; severe pulmonary or liver disease
  • Musculoskeletal, balance/gait issues, severe peripheral vascular disease, or neuropathy or other neurologic conditions limiting exercise
  • Self-report MVPA \<30 minutes
  • Upon initial screening, if the participant's baseline FitBit-measured MVPA ≥180 minutes/week (despite self-report range of 30-120 minutes), the participant will be further excluded.

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2027

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06938412

Start Date

October 1 2025

End Date

March 31 2027

Last Update

October 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029